COMP360
A New Dawn for Psychedelics: Compass Pathways Nears Major Phase 3 Psilocybin Results
Compass Pathways; COMP360; psilocybin; treatment-resistant depression; phase 3 trial; psychedelic therapy; FDA Breakthrough Therapy; mental health innovation